Contact
searchSearch
HMP Global

Vascular Disease Management

Recently Published

Dr Eric Scott
AMP 2026
Using Imaging to Choose Between Endovascular Therapy and Surgical Bypass
08/05/2026
Eric C. Scott, MD
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents a case-based discussion on how advanced vascular imaging should guide the decision between an endovascular-first or surgical bypass-first approach for patients with PAD and CLTI.
Dr Eric Scott presents presents...
08/05/2026
Vascular Disease Management
Dr Jos van den Berg
AMP 2026
What Data From a Pilot Study in Germany Tells Us About the Global Cost of CLTI
08/05/2026
Jos C. van den Berg, MD, PhD
Jos C. van den Berg, MD, PhD, presents findings from a pilot health economic analysis conducted in Germany that provides an important framework for understanding the true societal cost of CLTI.
Jos C. van den Berg, MD, PhD, presents findings from a pilot health economic analysis conducted in Germany that provides an important framework for understanding the true societal cost of CLTI.
Jos C. van den Berg, MD, PhD,...
08/05/2026
Vascular Disease Management
Dr Richard Neville
AMP 2026
What Is the Current Definition of CLTI and PAD?
08/05/2026
Richard Neville, MD
Richard F. Neville, MD, FACS, DFSVS, reviews the evolution of PAD and CLTI definitions, emphasizing that modern classification systems, earlier recognition, and multidisciplinary care are essential to reducing preventable amputations.
Richard F. Neville, MD, FACS, DFSVS, reviews the evolution of PAD and CLTI definitions, emphasizing that modern classification systems, earlier recognition, and multidisciplinary care are essential to reducing preventable amputations.
Richard F. Neville, MD, FACS,...
08/05/2026
Vascular Disease Management
Case Report
Extreme Limb Salvage Facilitated by Patient Advocacy, Multidisciplinary Care, and a Novel Stabilized Hypochlorous Acid Wound Therapy
07/22/2026
David E. Allie, MD; Kerry T. Thibodeaux, MD; Amit Amin, MD; Kym McNicholas
This case report describes an extreme limb salvage outcome.
This case report describes an extreme limb salvage outcome.
This case report describes an...
07/22/2026
Vascular Disease Management
Case Report
Off-Label Flow Diverter Stent as a Salvage Technique for Early Post-Liver Transplant Hepatic Arterial Occlusion: A Novel Technique
07/15/2026
Santhosh Babu K.B, MBBS, MD, FNVIR; Ashish Goel, DM, MD; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case...
07/15/2026
Vascular Disease Management
Case Series
Combined Rotational Atherectomy and Mechanical Thrombectomy for Debulking of Peripheral Chronic Total Occlusions
06/16/2026
Fares Jamal, DO; Marian Canon Feliciano, MD; Thomas P. Davis, MD, FACC
The authors describe the feasibility of a hybrid mechanical debulking strategy combining rotational atherectomy and mechanical thrombectomy for treatment of complex lower extremity CTO lesions.
The authors describe the feasibility of a hybrid mechanical debulking strategy combining rotational atherectomy and mechanical thrombectomy for treatment of complex lower extremity CTO lesions.
The authors describe the...
06/16/2026
Vascular Disease Management
Interview
Choosing Between Drug-Coated Balloons, Drug-Eluting Stents, and Bypass for Femoropopliteal Disease
06/15/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses how lesion characteristics, intravascular imaging, and patient-specific factors can guide treatment selection.
Mike Watts, MD, FSIR, discusses how lesion characteristics, intravascular imaging, and patient-specific factors can guide treatment selection.
Mike Watts, MD, FSIR, discusses...
06/15/2026
Vascular Disease Management
New Technique
Preoperative Devascularization of Large Neck Tumors Encasing the Internal Carotid Artery Using Hybrid Trapping Technique
06/08/2026
Rajat Singhal, DM, DNB, FRCR, EBIR; Rajchandra Singh Kharayat, DM, DNB; L. Samuel Prabhu Mithra, MCh, MS; Deepak Selvaraj, MCh, MS, MRCS; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a novel “technique of hybrid trapping” in a 32-year-old man with a Shamblin III carotid body tumor encasing the internal carotid artery.
The authors describe a novel “technique of hybrid trapping” in a 32-year-old man with a Shamblin III carotid body tumor encasing the internal carotid artery.
The authors describe a novel...
06/08/2026
Vascular Disease Management
Interview
Below-the-Knee Atherectomy Requires a Selective Approach
06/04/2026
Luke R. Wilkins, MD, FSIR
Drawing on current data and clinical experience, Dr Wilkins highlights the importance of thoughtful patient selection and lesion-specific decision-making to maximize outcomes.
Drawing on current data and clinical experience, Dr Wilkins highlights the importance of thoughtful patient selection and lesion-specific decision-making to maximize outcomes.
Drawing on current data and...
06/04/2026
Vascular Disease Management

Interventional Oncology

Liver Tumor Ablation
First Meta-analysis Supports Histotripsy for Liver Tumor Ablation
07/14/2026
Laura Simson, MA
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high...
07/14/2026
Vascular Disease Management
GPX Embolic Device
GPX® Embolic Device Meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
07/14/2026
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx...
07/14/2026
Vascular Disease Management
Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management
Transarterial Chemoembolization
STRIDE-Based Regimens Plus TACE Improve Outcomes vs TACE Alone in Embolization-Eligible Hepatocellular Carcinoma
07/13/2026
Stephanie Holland
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3...
07/13/2026
Vascular Disease Management
Embolization
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
07/02/2026
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02,...
07/02/2026
Vascular Disease Management

Videos

Ghassan Abou-Alfa headshot
ASCO 2026
Immunotherapy Plus TACE Emerges as a New Option for Intermediate-Stage Hepatocellular Carcinoma
07/13/2026
Ghassan Abou-Alfa, MD, MBA
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses phase 3 EMERALD-3 results showing that adding STRIDE (tremelimumab plus durvalumab) to transarterial chemoembolization significantly improved progression-free survival in patients with unresectable...
Ghassan Abou-Alfa, MD, discusses...
07/13/2026
Vascular Disease Management
Michael Pishvaian headshot
Interview
Intra-Arterial Gemcitabine for Patients With Locally Advanced Pancreatic Cancer
06/15/2026
Michael Pishvaian, MD, PhD
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD, discusses the phase 3 TIGeR-PaC study evaluating intra-arterial gemcitabine among patients with locally advanced pancreatic cancer.
Michael Pishvaian, MD, PhD,...
06/15/2026
Vascular Disease Management
Dr Kak Khee Yeung speaks at ISET 2026.
ISET 2026
Can AI Be of Value in Predicting Type B Dissection Progression Over Time?
04/16/2026
Kak Khee Yeung, MD, PhD
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD, explores the potential role of AI in predicting the progression of Type B aortic dissection over time.
Kak Khee Yeung, MD, PhD,...
04/16/2026
Vascular Disease Management
Dr Mouawad speaks at ISET 2026
ISET 2026
Advancing Thrombectomy and Autologous Blood Reinfusion for Pulmonary Embolism Treatment: Results from the AVENTUS Pivotal Study
04/09/2026
Nicolas J. Mouawad, MD, MPH, MBA
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results of the AVENTUS pivotal trial.
Dr Mouawad discusses the results...
04/09/2026
Vascular Disease Management
Dr S Jay Mathews speaks at ISET 2026
ISET 2026
Retrievable Scaffold Therapy: Results From Trials
04/07/2026
S. Jay Mathews, MD, MS, FACC, FSCAI
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest clinical data, discusses evolving techniques, and highlights how retrievable scaffold technology is shaping the future of vascular intervention.
Dr Mathews reviews the latest...
04/07/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Salazar speaks at ISET 2026
ISET 2026
Venous Valve Technology: When Will It Be Standard of Care?
04/01/2026
Gloria Salazar, MD, FSIR
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current state of venous valve technologies, including recent clinical progress and the challenges that remain before widespread adoption.
Dr Salazar examines the current...
04/01/2026
Vascular Disease Management
Dr Gunnar Tepe speaks at ISET 2026
ISET 2026
The State of DCB Technology in 2026: Where Are We Going?
03/31/2026
Gunnar Tepe, MD
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest clinical data, emerging innovations, and ongoing challenges shaping the field, offering insight into how DCB technology is redefining endovascular treatment strategies today—and where it may lead.
Dr. Tepe explores the latest...
03/31/2026
Vascular Disease Management
Dr Jacques Busquet speaks at ISET 2026.
ISET 2026
The Mystery of Post-EVAR Endotension
03/26/2026
Jacques Busquet, MD
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned cardiovascular and endovascular surgeon Jacques Busquet, MD, from Clinique Val d'Or in Paris, France, explores the mystery of post-EVAR endotension, expanding on insights from his presentation at ISET 2026.
In this video, renowned...
03/26/2026
Vascular Disease Management
Dr Sanjay Misra speaks at ISET 2026
ISET 2026
Renal Denervation for Refractory Hypertension: Indications, Data, and Outcomes
03/25/2026
Sanjay Misra, MD, FSIR, FAHA, FACR
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist Sanjay Misra, MD, FSIR, FAHA, FACR, from the Mayo Clinic, highlights key insights from his presentation on renal denervation for hypertension.
Interventional radiologist...
03/25/2026
Vascular Disease Management

Office-Based Labs (OBL) Corner

MSK Embolization
CUC America Announces Strategic Collaborations with Dr. Yuji Okuno and Dr. Osman Ahmed to Advance MSK Embolization and Expand Access to Minimally Invasive Pain Treatment in the United States
04/10/2026
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy and leading U.S. interventional radiologist join forces with CUC America to build a scalable Office-Based Laboratory (OBL) platform New Baltimore, MI — April 9, 2026 — CUC America, a leading provider of...
Global pioneer of embolotherapy...
04/10/2026
Vascular Disease Management
Dr Mary Costantino speaks at ISET 2026.
ISET 2026
Uterine Fibroid Embolization in the OBL: Patient Selection and Workflow Optimization
04/02/2026
Mary Costantino, MD, FSIR
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical strategies for identifying appropriate candidates and streamlining procedural workflows in the OBL setting, with a focus on improving efficiency, patient outcomes, and overall practice success.
Dr Costantino outlines practical...
04/02/2026
Vascular Disease Management
Dr Mike Watts
ISET 2026
How I Do It: Distal Deep Venous Arterialization in the OBL
02/11/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from Atlantic Medical Imaging in New Jersey, presented a practical, real-world approach to performing distal deep venous arterialization (dDVA) in the office-based lab.
Mike Watts, MD, FSIR, from...
02/11/2026
Vascular Disease Management
Craig Walker, MD
Video Commentary
Optimizing Safety and Outcomes in Outpatient Practice
01/19/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker discusses the article by Krishna Jain, MD, "Safety in Office-Based Laboratories and Ambulatory Surgery Centers".
In this video, Dr Walker...
01/19/2026
Vascular Disease Management
Clinical Editor's Corner
Ensuring Safety and Effectiveness in Outpatient Settings
01/16/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article...
01/16/2026
Vascular Disease Management

Editor's Corner

Clinical Editor's Corner
Expanding the Role of Embolic Protection in Peripheral Arterial Interventions
03/17/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease.”
Dr Walker comments on "Temporary...
03/17/2026
Vascular Disease Management
Clinical Editor's Corner
Ensuring Safety and Effectiveness in Outpatient Settings
01/16/2026
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article by Krishna Jain, MD, “Safety in Office-Based Laboratories and Ambulatory Surgical Centers”.
Dr Walker discusses the article...
01/16/2026
Vascular Disease Management
Clinical Editor's Corner
Changing the Present Algorithm of Evaluation and Therapy of Chronic Limb-Threatening Ischemia
11/20/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
Dr Walker discusses the article by Zarins and Krievens, "Chronic Limb-Threatening Ischemia: Are We Saving Limbs but Losing Lives?"
Dr Walker discusses the article...
11/20/2025
Vascular Disease Management
Clinical Editor's Corner
A Cost Analysis of Venous Thromboembolism Treatment
10/14/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Clinical Editor Dr Craig Walker comments on the article by Mary Yost, MBA, "The Cost of Venous Thromboembolism".
Clinical Editor Dr Craig Walker comments on the article by Mary Yost, MBA, "The Cost of Venous Thromboembolism".
Clinical Editor Dr Craig Walker...
10/14/2025
Vascular Disease Management
Editor's Corner
DVA Shows Great Promise in Saving Limbs, Saving Lives, and Reducing Healthcare Costs
09/19/2025
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the article by Randhawa, Thomas, and Siah entitled “Deep Vein Arterialization for No-Option Chronic Limb-Threatening Ischemia: An Overview of the LimFlow System and CLariTI Study”.
Dr Walker comments on the...
09/19/2025
Vascular Disease Management
Editor's Corner
The Importance of Simulation Training in Modern Medical Education
08/19/2024
Matthew T. Finn, MD, MS
Dr. Matthew Finn discusses the article by Soliman et al, “The Impact of Early Vascular Simulation Training in Medical School Education.”
Dr. Matthew Finn discusses the article by Soliman et al, “The Impact of Early Vascular Simulation Training in Medical School Education.”
Dr. Matthew Finn discusses the...
08/19/2024
Vascular Disease Management
Editor's Corner
Screening for Peripheral Arterial Disease
12/15/2023
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
In December's Editor's Corner, Dr. Walker asks if clinicians should be screening for peripheral arterial disease.
In December's Editor's Corner, Dr. Walker asks if clinicians should be screening for peripheral arterial disease.
In December's Editor's Corner,...
12/15/2023
Vascular Disease Management
Editor's Corner
Atherectomy in the Infrainguinal Arteries
10/30/2023
McCall Walker, MD; Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP; Sahil A. Parikh, MD, FACC, FSCAI; Matthew T. Finn, MD, MS
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports alleging overuse of atherectomy devices, the authors revisit the guidelines and clinical data as to inform the overall discourse surrounding the appropriate use of these devices.
In light of recent reports...
10/30/2023
Vascular Disease Management
Editor's Corner
Addressing the New York Times Controversy: Eroding Patient Trust
09/20/2023
Craig M. Walker, MD, FACC, FACP, FSCAI, FCCP
Dr. Walker discusses the recent controversy over the New York Times article on atherectomy.
Dr. Walker discusses the recent controversy over the New York Times article on atherectomy.
Dr. Walker discusses the recent...
09/20/2023
Vascular Disease Management
Editor's Corner
Dodging a Bullet
08/30/2023
Pradeep K. Nair, MD, FACC, FSCAI
Looking at a unique case.
Looking at a unique case.
Looking at a unique case.
08/30/2023
Vascular Disease Management

Clinical Insights

Case Report
Extreme Limb Salvage Facilitated by Patient Advocacy, Multidisciplinary Care, and a Novel Stabilized Hypochlorous Acid Wound Therapy
07/22/2026
David E. Allie, MD; Kerry T. Thibodeaux, MD; Amit Amin, MD; Kym McNicholas
This case report describes an extreme limb salvage outcome.
This case report describes an extreme limb salvage outcome.
This case report describes an...
07/22/2026
Vascular Disease Management
Case Report
Off-Label Flow Diverter Stent as a Salvage Technique for Early Post-Liver Transplant Hepatic Arterial Occlusion: A Novel Technique
07/15/2026
Santhosh Babu K.B, MBBS, MD, FNVIR; Ashish Goel, DM, MD; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case...
07/15/2026
Vascular Disease Management
Original Research
Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
Original Research
Association Between Peak Anti-Xa Activity and Bleeding Events in Patients Treated With NOACs
01/19/2026
Alberto Francesco Cereda, MD; Marco Biolcati, MD; Federico Biondi, MD; Marco Stracqualursi, MD; Antonio Gabriele Franchina, MD; Lorenzo Tua, MD; Stefano Lucreziotti, MD
This meta-analysis assesses the association between peak anti-Xa levels and bleeding events in patients treated with apixaban or rivaroxaban.
This meta-analysis assesses the association between peak anti-Xa levels and bleeding events in patients treated with apixaban or rivaroxaban.
This meta-analysis assesses the...
01/19/2026
Vascular Disease Management
Case Report
Femoral Vein Reconstruction: A Complicated Case Example Treating Chronic Venous Disease With a Modified Gun-Sight Technique
12/02/2025
Matthew Tiede, MD
The author presents a case of common femoral vein occlusion in a patient with Klippel-Trénaunay syndrome.
The author presents a case of common femoral vein occlusion in a patient with Klippel-Trénaunay syndrome.
The author presents a case of...
12/02/2025
Vascular Disease Management
Original Research
Trends in Vascular Surgery Activity: Results From the Spanish National Inpatient Registry Over an 18-Year Period (2005 to 2022) and Future Plan
10/24/2025
Sandra Vicente Jiménez, MD, PhD; Elia Perez-Fernández, MD; Carlos Maria Elvira-Martinez, MD; Patricia Lucia Barber-Pérez, MD; Manuel Maynar, MD, PhD; Luis de Benito, MD, PhD; Beatriz Gonzalez Lopez-Valcarcel, MD
The authors identify the main trends in diagnosis, procedures, and costs of angiology and vascular surgery in Spain over 18 years.
The authors identify the main trends in diagnosis, procedures, and costs of angiology and vascular surgery in Spain over 18 years.
The authors identify the main...
10/24/2025
Vascular Disease Management
Case Report
Aortic Endograft and Femorofemoral Bypass in a Patient With Acute Aortic Occlusion Post-COVID Respiratory Disease, Atrial Fibrillation, and Vocal Cord Cancer With Chronic Left External Iliac Occlusion
10/20/2025
Miguel Ignacio Herrero, MD; Sandra Vicente Jiménez, MD, PhD; Blanca Expósito Camacho, MD; Ignacio Querol Cisneros, MD; Marina Navarro Sáez, MD; Luis De Benito Fernandez, MD
The case of a 64-year-old man with bilateral acute ischemia.
The case of a 64-year-old man with bilateral acute ischemia.
The case of a 64-year-old man...
10/20/2025
Vascular Disease Management
Case Report
Limb Salvage in Complex Femoropopliteal Occlusion
09/22/2025
John H. Shao, MD; John Lee, MD; Haris Umer Usman, MD, MS
The authors describe the successful application of PTAB utilizing the Detour system (Endologix) as a limb salvage strategy for a patient with previously failed femoropopliteal bypass.
The authors describe the successful application of PTAB utilizing the Detour system (Endologix) as a limb salvage strategy for a patient with previously failed femoropopliteal bypass.
The authors describe the...
09/22/2025
Vascular Disease Management
Figure 1
Advertorial
Use of the Penumbra Indigo® System for Femoral Artery Thrombosis
09/16/2025
Diana Puicea, MD; Silvan Omerovic, DO; Umer Tariq, MD; Prasanna Sengodan, MD
In this case report, a 45-year-old man with a history of polysubstance abuse presented with intractable nausea and vomiting. Angiography confirmed left anterior descending patency but with significant thrombus burden.
In this case report, a 45-year-old man with a history of polysubstance abuse presented with intractable nausea and vomiting. Angiography confirmed left anterior descending patency but with significant thrombus burden.
In this case report, a...
09/16/2025
Vascular Disease Management
Case Report
May-Thurner Syndrome Masking Concomitant Arteriovenous Fistula: A Deadly Combination With Diagnostic and Therapeutic Challenges
04/30/2025
Amithavikrama Kheda, MD; Sharath BM, DNB, RD; Vijayalakshmi Devi Bodagala, DNB, RD; Neha Oruganti, MBBS; Sri Satyavathi Davuluri, MS, MCh
The authors present the case of a 56-year-old woman with left leg swelling and pain due to May-Thurner syndrome and an associated AVF that was successfully treated with endovascular techniques.
The authors present the case of a 56-year-old woman with left leg swelling and pain due to May-Thurner syndrome and an associated AVF that was successfully treated with endovascular techniques.
The authors present the case of...
04/30/2025
Vascular Disease Management

Read More

Case Report
Extreme Limb Salvage Facilitated by Patient Advocacy, Multidisciplinary Care, and a Novel Stabilized Hypochlorous Acid Wound Therapy
07/22/2026
David E. Allie, MD; Kerry T. Thibodeaux, MD; Amit Amin, MD; Kym McNicholas
This case report describes an extreme limb salvage outcome.
This case report describes an extreme limb salvage outcome.
This case report describes an...
07/22/2026
Vascular Disease Management
Case Report
Off-Label Flow Diverter Stent as a Salvage Technique for Early Post-Liver Transplant Hepatic Arterial Occlusion: A Novel Technique
07/15/2026
Santhosh Babu K.B, MBBS, MD, FNVIR; Ashish Goel, DM, MD; Shyamkumar Nidugala Keshava, MBBS, DMRD, DNB, FRCR, FRANZCR
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case report where an off-label technique was performed using a flow diverter stent.
The authors describe a case...
07/15/2026
Vascular Disease Management
Interview
Choosing Between Drug-Coated Balloons, Drug-Eluting Stents, and Bypass for Femoropopliteal Disease
06/15/2026
Mike Watts, MD, FSIR
Mike Watts, MD, FSIR, discusses how lesion characteristics, intravascular imaging, and patient-specific factors can guide treatment selection.
Mike Watts, MD, FSIR, discusses how lesion characteristics, intravascular imaging, and patient-specific factors can guide treatment selection.
Mike Watts, MD, FSIR, discusses...
06/15/2026
Vascular Disease Management
Interview
Below-the-Knee Atherectomy Requires a Selective Approach
06/04/2026
Luke R. Wilkins, MD, FSIR
Drawing on current data and clinical experience, Dr Wilkins highlights the importance of thoughtful patient selection and lesion-specific decision-making to maximize outcomes.
Drawing on current data and clinical experience, Dr Wilkins highlights the importance of thoughtful patient selection and lesion-specific decision-making to maximize outcomes.
Drawing on current data and...
06/04/2026
Vascular Disease Management
Interview
New MAUDE Analysis Highlights Real-World Mechanical Thrombectomy Complications
05/18/2026
Chloe Issa, MD; Sarah Montaquila, DO
Drs Issa and Montaquila discuss their analysis of FDA MAUDE data examining adverse events in venous and pulmonary mechanical thrombectomy systems.
Drs Issa and Montaquila discuss their analysis of FDA MAUDE data examining adverse events in venous and pulmonary mechanical thrombectomy systems.
Drs Issa and Montaquila discuss...
05/18/2026
Vascular Disease Management
Interview
New Insights on Thrombectomy in Atrial Fibrillation-Related Stroke
05/06/2026
Waseem Wahood, MD
Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.
Dr Wahood discusses trends reshaping the landscape of mechanical thrombectomy for acute ischemic stroke, particularly in patients with atrial fibrillation.
Dr Wahood discusses trends...
05/06/2026
Vascular Disease Management
Interview
Tackling the Calcium Challenge: Managing Recoil, Rupture, and Occlusion
04/22/2026
Kumar Madassery, MD
Dr Madassery explores why calcified lesions continue to complicate treatment.
Dr Madassery explores why calcified lesions continue to complicate treatment.
Dr Madassery explores why...
04/22/2026
Vascular Disease Management
Original Research
Temporary Occlusion Embolectomy: A Cost-Effective Approach to Distal Embolic Protection in Peripheral Artery Disease
03/18/2026
Tom Davis, MD; Peter Dovgan, MD; Eric J. Dippel, MD
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational case series evaluated embolic debris retrieval and procedural feasibility of temporary occlusion embolectomy during complex peripheral vascular interventions.
This retrospective observational...
03/18/2026
Vascular Disease Management
Interview
Advancing AI in IO: Dr Dania Daye on Improving Research Quality, Clinical Outcomes, and Patient Care
03/13/2026
Dania Daye, MD, PhD
Dr Dania Daye discusses the need for standardized reporting in AI studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need for standardized reporting in AI studies and reflects on key themes from her recent keynote at the Society of Interventional Oncology (SIO) conference.
Dr Dania Daye discusses the need...
03/13/2026
Vascular Disease Management
Interview
Standardizing the Workup: Best Practices for Comprehensive Noninvasive Evaluation in Chronic Limb-Threatening Ischemia
03/11/2026
Srini Tummala, MD
Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.
Dr. Srini Tummala outlines the essential components of a high-quality noninvasive vascular assessment for patients with chronic limb-threatening ischemia.
Dr. Srini Tummala outlines the...
03/11/2026
Vascular Disease Management

Stay in the Know

Vascular Disease Management Newsletter

News

Press Release
Fluidx Completes Submission of Premarket Approval Application for the GPX® Embolic Device
07/24/2026
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026 Fluidx Medical Technology, Inc., a clinical stage medical device company advancing its portfolio of embolic technologies, announced that it recently submitted to the U.S. Food and Drug Administration (FDA) the...
Salt Lake City (UT) – 07/24/2026...
07/24/2026
Vascular Disease Management
Thrombectomy
THUNDER Study Demonstrates Penumbra’s THUNDERBOLT is Safe and Effective for Stroke Care
07/22/2026
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif. – Penumbra, Inc. announced the results of THUNDER, an Investigational Device Exemption (IDE) study, to evaluate the safety and effectiveness of THUNDERBOLT™, the company’s novel...
ALAMEDA, Calif....
07/22/2026
Cath Lab Digest
Stroke Interventions
Imperative Care Launches Ikon 24 Pro Guidewire, Enhancing the Zoom Stroke System to Support More Efficient Stroke Procedures
07/17/2026
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026 — Imperative Care, a medical technology company focused on advancing treatments for patients suffering from thromboembolic disease, today announced the launch of the Ikon™ 24 Pro Guidewire, a next-generation...
CAMPBELL, Calif., July 16, 2026...
07/17/2026
Vascular Disease Management
Liver Tumor Ablation
First Meta-analysis Supports Histotripsy for Liver Tumor Ablation
07/14/2026
Laura Simson, MA
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high technical success and an encouraging safety profile for the treatment of primary and secondary liver tumors in the first systematic review and meta-analysis to report the technology's clinical evidence.
Histotripsy demonstrated high...
07/14/2026
Vascular Disease Management
Radiation Safety
Landmark Multi-Society Consensus Signals New Era in Occupational Radiation Safety; Rampart Positioned to Accelerate Adoption of Lead-Free Enhanced Radiation Protection
07/14/2026
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026 — Rampart, the global leader in enhanced radiation protection devices (ERPD), today welcomed the publication of a landmark multi-society expert consensus statement that calls for a fundamental shift in...
BIRMINGHAM, Ala. — July 14, 2026...
07/14/2026
Vascular Disease Management
GPX Embolic Device
GPX® Embolic Device Meets Primary Endpoints in an Investigational Device Exemption (IDE) Pivotal Trial
07/14/2026
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx Medical Technology, Inc. announced the positive results from the Investigational Device Exemption (IDE) pivotal clinical trial evaluating the GPX Embolic Device. In the 114 patients that were treated in the trial,...
Salt Lake City (UT) – Fluidx...
07/14/2026
Vascular Disease Management
Transarterial Chemoembolization
STRIDE-Based Regimens Plus TACE Improve Outcomes vs TACE Alone in Embolization-Eligible Hepatocellular Carcinoma
07/13/2026
Stephanie Holland
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3 EMERALD-3 trial demonstrated that combining STRIDE-based immunotherapy with TACE, with or without lenvatinib, significantly improved progression-free survival compared with TACE alone, supporting a potential new...
Results from the phase 3...
07/13/2026
Vascular Disease Management
Peripheral Intervention
3-Year DETOUR2 Results Demonstrate Sustained Symptom Relief and Limb Preservation in Complex SFA Disease
07/09/2026
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first studies in long-segment (>30 cm) FP disease show durable patency, low reintervention rate, and high limb salvage through 36 months.
Data from one of the first...
07/09/2026
Cath Lab Digest
Thrombectomy for Stroke
First Patient Enrolled in Penumbra’s FORWARD Study Evaluating Mechanical Thrombectomy and Computer Assisted Vacuum Thrombectomy for Distal Acute Ischemic Stroke
07/07/2026
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc. announced the initiation of its FORWARD study, an international, real world prospective, multi-center study. The study will collect safety and efficacy data on mechanical thrombectomy, including computer...
ALAMEDA, Calif. - Penumbra, Inc....
07/07/2026
Cath Lab Digest
Embolization
Fluidx Announces Continued Clinical Success with ULTRA Embolic Gel
07/02/2026
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02, 2026 — Fluidx Medical Technology, Inc. today announced that its ULTRA Embolic Device continues to see clinical success and was most recently used to treat a large, right-sided renal cell carcinoma (RCC) tumor at...
SALT LAKE CITY, UT — July 02,...
07/02/2026
Vascular Disease Management

HMP Global Products

Events

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2026 HMP Global. All Rights Reserved.
Cookie Policy Privacy Policy Terms of Use